Bosco & Crossy's stock picks,talk area Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bosco & Crossy's stock picks,talk area

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Crossy who wrote (4526)	1/7/2004 8:15:53 AM
From: Crossy	of 37387

re: Vital Biotech (1164.HK) - HK$0.80 well I just found a fairly current research report from last fall issued by Core Pacific / Yamichi .. they maintain their BUY rating on Vital with a target price of HK$1.06 I would maintain that this is a shortterm target only IMHO, no success from future revenue streams seems to be priced in here.. iprasia.com what I like particularly is that a new collaboration with ALK was mentioned to jointly provide Allergy vaccines. This is a fairly "hot" sector of the pharma universe, even in very developed markets like the US or Europe. Tangible commercial results from this project could be expected in a 2-4 year time frame. check it yourself ! CROSSY

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next